Table 1 Summary of studies assessing the relationship between inflammation on baseline STIR MRI of the spine and development of new syndesmophytes after 2 years of follow up
| Â | Number of patients with new syndesmophytes at 2 years | Â | Â | |
|---|---|---|---|---|
Study | Yes | No | OR (95% CI) | P-value |
Baraliakos et al. [19] | Â | Â | Â | Â |
   Baseline VE+ (n = 163; 17.2%) | 10 (6.5%) | 153 (93.5%) | 3.1 (1.4-7.1) | 0.007 |
   Baseline VE- (n = 785; 82.8%) | 16 (2.1%) | 769 (97.9%) |  |  |
Maksymowych et al. [20] | Â | Â | Â | Â |
Anti-TNFα trial patients |  |  |  |  |
   Baseline CIL+ (n = 30) | 6 (20%) | 24 (80%) | 4.6 (1.7-12.6) | 0.007 |
   Baseline CIL- (n = 370) | 19 (5.1%) | 351 (94.9%) |  |  |
   Observational cohort patients |  |  |  |  |
   Baseline CIL+ (n = 28) | 6 (15.8%) | 32(84.2%) | 6.3 (2.4-16.7) | 0.001 |
   Baseline CIL- (n = 617) | 23 (2.9%) | 778 (97.1%) |  |  |
Van der Heijde et al. [21] | Â | Â | Â | Â |
   Baseline DVU+ (n = 297) | 36 (12.1%) | 261 (87.9%) | 1.9 (1.3-2.8) | 0.002 |
   Baseline DVU- (n = 1,707) | 115 (6.7%) | 1,592 (93.3%) |  |  |